CITIC Securities: After the mid-term report, performance upgrades are concentrated in pharmaceuticals, TMT, and mid-to-high-end manufacturing, with revenue or profit reaching historical highs for the same period

Zhitong
2025.09.07 00:41
portai
I'm PortAI, I can summarize articles.

China Merchants Securities released a research report indicating that the upward revision of mid-year performance in 2025 is mainly concentrated in the pharmaceutical, TMT, and mid-to-high-end manufacturing sectors, with expected revenue or profit reaching historical highs. The earnings expectations of 794 A-share listed companies have been adjusted upward, benefiting from factors such as the overseas expansion of innovative drugs, capital expenditures in cloud manufacturing, and domestic substitution in semiconductors. It is recommended to pay attention to industries such as digital chip design, communication network equipment, gaming, and lithium batteries